Chihuahua and Neuronal Ceroid Lipofuscinosis (NCL / MFSD8·CLN7): What a DNA Test Can and Can’t Tell You

Conclusion: Neuronal ceroid lipofuscinosis (NCL) in Chihuahuas is reported to be caused by the MFSD8 (CLN7) variant c.846delT, inherited in an autosomal recessive pattern, and it is an early-onset progressive neurodegenerative disease that typically begins around one year of age with vision loss and ataxia (Faller 2016). Keep one thing clear, though: a DNA test tells you about genetics and breeding risk, not a clinical diagnosis. An actual diagnosis requires evaluation by a veterinarian, ideally a board-certified veterinary neurologist, and no cure has been reported to date. This article is informational only, so please consult your own vet about diagnosis and care.

What NCL Is: The MFSD8 (CLN7) Mechanism in Chihuahuas

SamI only just learned Chihuahuas can get something called NCL, and now I’m worried about my dog.

Elena MarshNCL is a group of diseases where lysosomal breakdown fails and waste piles up inside neurons (Katz 2017). Let’s start with the mechanism.

Neuronal ceroid lipofuscinosis (NCL), sometimes called canine Batten disease, is a family of inherited lysosomal storage disorders in which the cell’s recycling center, the lysosome, cannot break down waste properly. In their comprehensive review, Katz and colleagues (2017) describe how autofluorescent ceroid- and lipofuscin-like storage material accumulates progressively inside neurons and other cells. Because mature neurons are post-mitotic and cannot dilute this waste by dividing, the storage bodies build up relentlessly and drive progressive neuronal death in the brain, cerebellum, and retina. In Chihuahuas the responsible gene is MFSD8, also known as CLN7. Faller and colleagues (2016) studied two littermate Chihuahuas in detail and identified a single-base deletion in MFSD8, c.846delT (at the protein level, p.Phe282Leufs13*), as the causal frameshift variant. This is the same variant previously reported in a Chinese Crested dog. The inheritance is autosomal recessive, meaning a dog must inherit a defective copy from both parents for the disease to develop, while a dog with a single copy is a healthy carrier.

How It Presents in Chihuahuas: Early and Progressive Decline

SamIf my Chihuahua did develop it, what would the very first signs look like?

Elena MarshIn Faller’s (2016) cases the dogs showed failing vision and wobbliness from about one year of age, and it progressed steadily.

In the Chihuahuas described by Faller and colleagues (2016), signs began around one year of age and included progressive blindness, cerebellar ataxia (an unsteady, wobbly gait), repetitive pacing, and cognitive impairment such as the loss of previously learned behaviors. Histopathology confirmed autofluorescent storage bodies in the brain, matching the lysosomal storage mechanism described above. In that report the disease progressed until the dogs reached a grave prognosis and were euthanized at roughly two years of age. This places Chihuahua NCL among the early-onset canine forms, alongside the CLN8 form well known in English Setters (onset around 12 to 18 months). Two cautions matter here. First, what is described above is the typical course reported in a small case study, not a guarantee that every affected Chihuahua will present or progress identically. Second, no owner should try to judge these signs by appearance or speed of change alone. If you notice anything concerning, such as bumping into furniture, circling, or a loss of house-trained habits, book a veterinary exam rather than self-diagnosing.

Frequency and Inheritance: How Common Are Silent Carriers?

SamBut this has to be extremely rare, right? Surely it’s not something I need to think about.

Elena MarshA screen of 1,007 Chihuahuas in Japan found a 1.29% carrier rate, high enough that the authors urged control measures (Pervin 2022).

Because NCL is recessive, a dog carrying just one copy of the variant is a clinically normal, healthy-looking carrier, and that is exactly where the risk hides. The best available screening data come from Japan: Pervin and colleagues (2022) screened 1,007 Chihuahua puppies for the MFSD8/CLN7 c.846delT variant and reported a carrier rate of 1.29% with a mutant allele frequency of 0.00645. The authors judged this frequency high enough to warrant control and prevention measures. That study is a Japanese cohort, so the exact figure may differ in US and UK populations, but the takeaway travels well: the Chihuahua is one of the most popular toy breeds registered with both the American Kennel Club (AKC) and the UK Kennel Club, and with a large breeding population the chance of two silent carriers being paired is not negligible. Since carriers show no signs and cannot be spotted by looks, Katz and colleagues (2017) note that pre-breeding DNA carrier testing is the only reliable way to avoid producing affected puppies. Identify the carriers, pair them only with clear (non-carrier) mates, and you prevent affected offspring while preserving genetic diversity.

How to Test in the US and UK: Labs, Swabs, and the Vet Pathway

SamOkay, I want to test. But where do owners in the US or UK actually go for this?

Elena MarshConsumer labs like Embark and Wisdom Panel run recessive NCL panels from a home cheek swab, the same recessive model documented across the studies (Katz 2017).

In the United States and the United Kingdom, most owners start with a direct-to-consumer (DTC) DNA kit. Embark and Wisdom Panel both offer broad health panels that include NCL variants, and Paw Print Genetics (now part of Orivet) offers clinical-grade breed-specific NCL tests. The sample is simple: you collect a cheek (buccal) swab at home, seal it, and mail it back domestically within the US or UK, with results typically returned in a few weeks. One step is essential before you order: confirm that the provider’s panel actually covers the Chihuahua MFSD8/CLN7 (NCL7) c.846delT variant, because panels vary and not every NCL test targets this specific gene. On cost, a single-condition test is generally cheaper than a broad multi-condition panel, but pricing changes often, so check the provider’s current rates rather than relying on any quoted figure.

The clinical pathway is separate from the DNA kit. If your Chihuahua is showing signs, start with your primary-care veterinarian, who can then refer you to a board-certified veterinary neurologist. In the US that means an ACVIM (neurology) specialist; in the UK, an RCVS or ECVN recognized specialist. It is also worth understanding what testing is and is not regulated. There is no pet equivalent of the human Genetic Information Nondiscrimination Act (GINA): canine DNA carrier testing is voluntary and largely unregulated, used chiefly for breeding decisions rather than mandated by any authority. Finally, plan for cost realistically. US and UK pet insurers commonly exclude hereditary, congenital, and pre-existing conditions, so a diagnosed inherited disease like NCL may not be covered. The exact wording varies from policy to policy, so read your terms and check directly with the insurer before assuming anything is included.

What a DNA Test Can and Cannot Tell You

SamSo once the DNA result comes back, can I treat that as a diagnosis and be done?

Elena MarshNo, keep those separate. A DNA test gives genotype and breeding information; clinical diagnosis is the vet’s call (Katz 2017).

A DNA test tells you one genetic fact: whether your dog is clear (no copies of the MFSD8/CLN7 variant), a carrier (one copy), or has the affected genotype (two copies). That is genuinely useful for planning matings, because pairing a carrier with a clear mate lets you avoid affected puppies by design. What a DNA test cannot do is diagnose disease. Whether and how far neurological or retinal changes have actually developed is a judgment for a veterinarian, and specifically a veterinary neurologist, based on examination and workup. Even a result of the affected genotype should be interpreted and acted on together with a specialist, not treated as a self-contained verdict, and nothing here should be read as instruction to start or change any treatment. It also bears repeating that no cure for NCL has been reported to date (Katz 2017). The role of a DNA test is limited to providing information and supporting breeding decisions. The most reliable approach, then, is to use the two tools for their proper jobs: pre-breeding DNA carrier testing to plan matings, and hands-on veterinary evaluation whenever real clinical signs appear.

What to Do If You’re Worried, and Breeding Decisions

SamI’ve read all this and I’m still anxious. What’s my actual next step?

Elena MarshMatch the action to the goal: a vet exam for symptoms, a carrier DNA test for breeding, which is exactly the prevention strategy the literature endorses (Katz 2017).

Start by separating two different questions. If your Chihuahua is showing possible signs, such as failing vision, an unsteady gait, pacing, or changes in learned behavior, the next step is a veterinary exam, with a referral to a board-certified neurologist if warranted, rather than ordering a home kit. A DNA test is not the tool for diagnosing a dog that is already symptomatic. If instead you are a breeder or planning a litter, the DNA carrier test is exactly the right tool. Responsible breeders working within the AKC and UK Kennel Club communities use carrier testing to pair carrier dogs only with clear mates, which prevents affected puppies while keeping valuable carriers in the gene pool and preserving diversity. Before you buy, verify the provider covers the Chihuahua MFSD8/CLN7 variant, and check current pricing. Whatever you decide, treat this article as background reading and let your own veterinarian guide the specifics for your dog.

Frequently Asked Questions

Q. Is Chihuahua NCL rare enough that I can ignore it?
It is uncommon, but not something to dismiss. A screen of 1,007 Chihuahua puppies in Japan found an MFSD8/CLN7 carrier rate of 1.29% (mutant allele frequency 0.00645), and the researchers judged that high enough to warrant control measures (Pervin 2022). That is a Japanese cohort, but because the Chihuahua is such a popular breed in the US and UK too, pre-breeding carrier testing is worth considering.

Q. Where and how do I test a Chihuahua in the US or UK?
Consumer labs such as Embark and Wisdom Panel, and clinical-grade providers like Paw Print Genetics (now Orivet), offer health panels using a home cheek swab that you mail back domestically, with results in a few weeks. Confirm the panel includes the Chihuahua MFSD8/CLN7 (NCL7) variant before ordering, and check the provider’s current pricing, since a single-condition test usually costs less than a broad multi-panel.

Q. Will my pet insurance cover NCL treatment?
Quite possibly not. US and UK pet insurers commonly exclude hereditary, congenital, and pre-existing conditions, which can include an inherited disease like NCL. The exact exclusions vary by policy, so read the wording and confirm with your insurer before assuming any coverage.

Q. If I run a DNA test, do I still need to see a vet?
Yes. A DNA test gives genetic risk and breeding information, not a clinical diagnosis. Assessing actual signs and their progression is the job of a veterinarian, ideally a board-certified neurologist (ACVIM in the US, RCVS/ECVN in the UK). If anything concerns you, see your primary-care vet first and ask for a specialist referral if needed.

References

• Faller KME et al. (2016) The Chihuahua dog: A new animal model for neuronal ceroid lipofuscinosis CLN7 disease? Journal of Neuroscience Research 94(4):339-347. https://pubmed.ncbi.nlm.nih.gov/26762174/
• Pervin S et al. (2022) Screening and Carrier Rate of Neuronal Ceroid Lipofuscinosis in Chihuahua Dogs in Japan. Animals (Basel) 12(9):1210. https://pmc.ncbi.nlm.nih.gov/articles/PMC9106037/
• Katz ML et al. (2017) Canine neuronal ceroid lipofuscinoses: Promising models for preclinical testing of therapeutic interventions. Neurobiology of Disease. https://pmc.ncbi.nlm.nih.gov/articles/PMC5675811/
• Guo J et al. (2014) MFSD8 frameshift variant in dogs with neuronal ceroid lipofuscinosis (OMIA:001962-9615, NCL type 7). Online Mendelian Inheritance in Animals. https://www.omia.org/OMIA001962/9615/
• Orthopedic Foundation for Animals (OFA) (2024) Neuronal Ceroid Lipofuscinosis — breed-specific DNA test registry. https://ofa.org/neuronal-ceroid-lipofuscinosis/

About the author

Elena Marsh

Editor & writer (not a veterinarian)

A writer with a molecular-biology background and a lifelong dog and cat owner. Not a veterinarian — she translates peer-reviewed genetics research and primary data into plain language, always as information rather than diagnosis.